Correlation Between Rocket Pharmaceuticals and Avidity Biosciences

Can any of the company-specific risk be diversified away by investing in both Rocket Pharmaceuticals and Avidity Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rocket Pharmaceuticals and Avidity Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Rocket Pharmaceuticals and Avidity Biosciences, you can compare the effects of market volatilities on Rocket Pharmaceuticals and Avidity Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rocket Pharmaceuticals with a short position of Avidity Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rocket Pharmaceuticals and Avidity Biosciences.

Diversification Opportunities for Rocket Pharmaceuticals and Avidity Biosciences

-0.2

Correlation Coefficient

Rocket Pharmaceuticals  Avidity Biosciences

Good diversification

The 3 months correlation between Rocket and Avidity is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Rocket Pharmaceuticals and Avidity Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avidity Biosciences and Rocket Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rocket Pharmaceuticals are associated (or correlated) with Avidity Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avidity Biosciences has no effect on the direction of Rocket Pharmaceuticals i.e., Rocket Pharmaceuticals and Avidity Biosciences go up and down completely randomly.

Pair Corralation between Rocket Pharmaceuticals and Avidity Biosciences

Given the investment horizon of 90 days Rocket Pharmaceuticals is expected to under-perform the Avidity Biosciences. In addition to that, Rocket Pharmaceuticals is 2.07 times more volatile than Avidity Biosciences. It trades about -0.05 of its total potential returns per unit of risk. Avidity Biosciences is currently generating about 0.17 per unit of volatility. If you would invest  3,022  in Avidity Biosciences on May 18, 2025 and sell it today you would earn a total of  1,625  from holding Avidity Biosciences or generate 53.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Rocket Pharmaceuticals  vs.  Avidity Biosciences

Rocket Pharmaceuticals

Risk-Adjusted Performance

Weakest

Over the last 90 days Rocket Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward-looking signals remain comparatively stable which may send shares a bit higher in September 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Avidity Biosciences

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Avidity Biosciences are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting basic indicators, Avidity Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Rocket Pharmaceuticals and Avidity Biosciences

The main advantage of trading using opposite Rocket Pharmaceuticals and Avidity Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rocket Pharmaceuticals position performs unexpectedly, Avidity Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avidity Biosciences will offset losses from the drop in Avidity Biosciences' long position.

The idea behind Rocket Pharmaceuticals and Avidity Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.